About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $1.4B
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Portfolio

Follow Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A., based on Form 13F filings with the SEC.

News

Stay updated on Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. with notifications on news.